Andrew Zannettino


  • 11097 Citations
  • 57 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output


Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Lee, O. L., Horvath, N., Lee, C., Joshua, D., Ho, J., Szer, J., Quach, H., Spencer, A., Harrison, S., Mollee, P., Roberts, A. W., Talaulikar, D., Brown, R., Augustson, B., Ling, S., Jaksic, W., Gibson, J., Kalff, A., Johnston, A., Kalro, A. & 3 others, Ward, C., Prince, H. M. & Zannettino, A., 1 Aug 2017, In : Internal Medicine Journal. 47, 8, p. 938-951 14 p.

Research output: Contribution to journalLetter

9 Citations (Scopus)
15 Citations (Scopus)

Circulating levels of TWEAK correlate with bone erosion in multiple myeloma patients

Williams, S. A., Martin, S. K., Vincent, C., Gronthos, S., Zheng, T., Atkins, G. J. & Zannettino, A. C. W., 1 Aug 2010, In : British Journal of Haematology. 150, 3, p. 373-376 4 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)

Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?

Labrinidis, A., Liapis, V., Thai, L. M., Atkins, G. J., Vincent, C., Hay, S., Sims, N. A., Zannettino, A. C. W., Findlay, D. M. & Evdokiou, A., 1 Jun 2008, In : Blood. 111, 11, p. 5411-5412 2 p.

Research output: Contribution to journalLetter

16 Citations (Scopus)

Identification and Clinical Relevance of Receptor Activator of Nuclear Factor κB Ligand Expression of Myeloma Cells [2] (multiple letters)

Heider, U., Zavrski, I., Jakob, C., Fleissner, C., Sezer, O., Zannettino, A. C. W., Pan, B., Farrugia, A. N., Atkins, G. J. & Bik To, L., 15 Jan 2004, In : Cancer Research. 64, 2, p. 773-775 3 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)